Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circular RNA Platform for the Diagnosis and Prognosis of Alzheimer’s Disease

Circular Genomics’ move to the Lilly Gateway Labs community will enhance scientific collaboration and innovation to foster the development of its Alzheimer’s disease diagnostic and prognostic blood tests SAN DIEGO, March 17, 2025 /PRNewswire/ — Circular Genomics, a global leader in…